Short-term outcomes of capecitabine plus oxaliplatin versus S-1 plus oxaliplatin as adjuvant chemotherapies for advanced gastric cancer after laparoscopic gastrectomy and D2 resection: A prospective, multicenter randomized, controlled clinical trial

被引：0
|
作者：
Yan, Y. [1 ]
Lu, L. [1 ]
Wang, X. [1 ]
Wang, D. [1 ]
Huang, Q. [2 ]
Zhao, Q. [3 ]
Liu, T. [1 ]
Fu, W. [1 ]
机构：
[1] Tianjin Med Univ, Tianjin, Peoples R China
[2] Shanxi Prov Canc Hosp, Taiyuan, Shanxi, Peoples R China
[3] Hebei Med Univ 4 Hosp, Shijiazhuang, Hebei, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.04.149
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-67
引用
收藏
页码：S111 / S111
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant docetaxel, oxaliplatin plus capecitabine versus oxaliplatin plus capecitabine for patients with locally advanced gastric adenocarcinoma: long-term results of a phase III randomized controlled trial
    Tian, Yuan
    Yang, Peigang
    Guo, Honghai
    Liu, Yang
    Zhang, Ze
    Ding, Pingan
    Zheng, Tao
    Deng, Huiyan
    Ma, Wenqian
    Li, Yong
    Fan, Liqiao
    Zhang, Zhidong
    Wang, Dong
    Zhao, Xuefeng
    Tan, Bibo
    Liu, Yu
    Zhao, Qun
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (12) : 4000 - 4008
  • [22] Effect of S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Plus Oxaliplatin as Perioperative Chemotherapy for Locally Advanced, Resectable Gastric Cancer A Randomized Clinical Trial
    Yu, Jiren
    Gao, Yuan
    Chen, Li
    Wu, Dan
    Shen, Qianyun
    Zhao, Zhicheng
    Liu, Weihuai
    Yang, Hanliang
    Zhang, Qi
    Wang, Xinbao
    Hu, Ping
    Zheng, Zhiqiang
    Wang, Xianfa
    Liu, Hongjun
    Xu, Zekuan
    Yan, Zhilong
    Wu, Yingjie
    Jin, Mingjuan
    Zhang, Qing
    Liu, Xiaosun
    Zhu, Kankai
    Shou, Chunhui
    JAMA NETWORK OPEN, 2022, 5 (02)
  • [23] Overall survival of perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in locally advanced gastric or gastrooesophageal junction adenocarcinoma undergoing D2 gastrectomy: An updated analysis of RESOLVE trial
    Zhang, X.
    Li, Z.
    Liang, H.
    Xue, Y.
    Wang, Y.
    Zhou, Z.
    Yu, J.
    Chen, L.
    Du, Y.
    Li, G.
    Xiao, G.
    Wu, D.
    Zhou, Y.
    Dang, C.
    He, Y.
    Zhang, Z.
    Sun, Y.
    Li, Y.
    Shen, L.
    Ji, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S1318 - S1319
  • [24] Adjuvant nab-paclitaxel plus S-1 versus capecitabine plus oxaliplatin for patients with stage III gastric adenocarcinoma after D2 dissection: A multicenter, open-label, randomized phase 3 study
    Yu, Pengfei
    Du, Yian
    Xu, Zhiyuan
    Yang, Litao
    Ying, Jieer
    Chen, Ping
    Wei, Yunhai
    Wu, Yingjie
    Zhang, Xiaojing
    Yan, Zhilong
    Chen, Zhiheng
    Xu, Hongtao
    Li, Yong
    Zheng, Zhichao
    Xu, Nong
    Cheng, Xiangdong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [25] Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection.
    Shin, Kabsoo
    Kim, In-Ho
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [26] Comparison of efficacy of aspirin plus epirubicin, oxaliplatin, and capecitabine versus epirubicin, oxaliplatin, and capecitabine alone in patients with locally advanced and metastatic gastric cancer: A randomized clinical trial
    Jafa, Esha
    Dubashi, Biswajit
    Kayal, Smita
    Kate, Vikram
    Ganesh, Rajesh Nachiappa
    Sunitha, V. C.
    Charles, L.
    Nisha, Yadav
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [27] Perioperative chemotherapy of oxaliplatin combined with S-1 (SOX) versus postoperative chemotherapy of SOX or oxaliplatin with capecitabine (XELOX) in locally advanced gastric adenocarcinoma with D2 gastrectomy: A randomized phase III trial (RESOLVE trial)
    Ji, J.
    Shen, L.
    Li, Z.
    Zhang, X.
    Liang, H.
    Xue, Y.
    Wang, Y.
    Zhou, Z.
    Yu, J.
    Chen, L.
    Du, Y.
    Li, G.
    Xiao, G.
    Wu, D.
    Zhou, Y.
    Dang, C.
    He, Y.
    Zhang, Z.
    Sun, Y.
    Li, Y.
    ANNALS OF ONCOLOGY, 2019, 30 : 877 - 877
  • [28] Short-term surgical outcomes of a randomized controlled trial comparing laparoscopic versus open gastrectomy with D2 lymph node dissection for advanced gastric cancer
    Yan Shi
    Xianhui Xu
    Yongliang Zhao
    Feng Qian
    Bo Tang
    Yingxue Hao
    Huaxing Luo
    Jun Chen
    Peiwu Yu
    Surgical Endoscopy, 2018, 32 : 2427 - 2433
  • [29] Short-term surgical outcomes of a randomized controlled trial comparing laparoscopic versus open gastrectomy with D2 lymph node dissection for advanced gastric cancer
    Shi, Yan
    Xu, Xianhui
    Zhao, Yongliang
    Qian, Feng
    Tang, Bo
    Hao, Yingxue
    Luo, Huaxing
    Chen, Jun
    Yu, Peiwu
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2018, 32 (05): : 2427 - 2433
  • [30] Neoadjuvant docetaxel, oxaliplatin, and s-1 plus surgery and adjuvant s-1 for resectable advanced gastric cancer: Final survival outcomes of the randomized phase 3 PRODIGY trial
    Kang, Yoon-Koo
    Kim, Hyung-Don
    Yook, Jeong Hwan
    Park, Young-Kyu
    Kim, Young-Woo
    Kim, Jin Young
    Ryu, Min-Hee
    Rha, Sun Young
    Chung, Ik-Joo
    Kim, In-Ho
    Oh, Sang Cheul
    Yoo, Chang Hak
    Kang, Seok Yun
    Zang, Dae Young
    Kim, Sunju
    Noh, Sung Hoon
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345